Nestle Purina starts 2015 off on the wrong foot – with a warning letter from the FDA

What a way to start off the year! Nestle Purina PetCare recently learned that it had violated federal regulations during the manufacture of dog and cat foods in one of its pet food plants.

The U.S. Food and Drug Administration’s letter was released to the public last week, in regards to “significant violations” that were observed at a Purina pet food plant in Allentown, Pennsylvania during an inspection last year. One particular worry had to do with the pet food company’s low-acid dog and cat food that was possibly prepared or packed improperly.

Related:Jerky Treats Made In China Linked To Nearly 600 Pet Deaths

These alleged violations were observed during a plant inspection that took place between Sept. 15 and Oct. 1, 2014. In the warning letter, Alpo Chop House Rotisserie Chicken flavor in Gourmet Gravy, Mighty Dog Chicken & Smoked Bacon Combo, Friskies Mariner’s Catch and Friskies Mixed Grill were cited as products prepared or packed improperly.

The letter listed six “significant violations” and efforts the company is taking to correct the “objectionable conditions.” As part of the significant violations, the FDA inspectors say Nestle Purina failed to:

It seems that Purina doesn’t think the FDA findings are all that serious. Keith Schopp, a spokesman for Nestle Purina, said Purina is confident there are no food safety issues or risks to pet health with the company’s products. If fact, he thinks this isn’t a Purina problem… it’s the FDA’s fault. Schopp said that the “FDA notice covers oversights in administrative activities and record keeping — not incidents of contamination at the plant.”

But the FDA is taking it seriously. Nestle Purina had 15 days (the letter is dated January 2, 2015) to provide adequate evidence of corrective action. If the company doesn’t correct the problem or fails to prevent the violations from happening again, Purina may get slapped with an injunction or seizure of product.

You can read the letter in its entirety on the FDA website.